Javascript must be enabled to continue!
Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease
View through CrossRef
AbstractBackgroundPatient‐rated motor symptoms (PRMS) and clinician‐rated motor symptoms (CRMS) often differ in Parkinson's disease (PD).ObjectiveOur goal was to investigate the determinants and clinical implications of PRMS compared with CRMS in PD.MethodsThis retrospective, observational cohort study analyzed the cross‐sectional associations and longitudinal impacts of PRMS as assessed by the Movement Disorders Society‐sponsored Unified PD Rating Scale (MDS‐UPDRS) part 2, while controlling for CRMS measured by MDS‐UPDRS part 3. Longitudinal analyses used Cox proportional hazards models and multiple linear mixed‐effects random intercepts/slope models, adjusting for many clinical predictors. We conducted propensity score matching (PSM) to reinforce our analyses' robustness and surface‐based morphometry to investigate neural correlates.ResultsWe enrolled 442 patients with early‐stage PD. At baseline, regardless of CRMS, PRMS were associated with the severity of postural instability and gait disturbance (PIGD). Notably, PRMS independently and more accurately predicted faster long‐term deterioration in motor function than CRMS (Hoehn and Yahr 4, adjusted hazard ratio per +1 point = 1.19 [95% confidence intervals, 1.08–1.32]), particularly in PIGD (PIGD subscore, β‐interaction = 0.052 [95% confidence intervals, 0.018–0.086]). PSM confirmed these findings' robustness. Surface‐based morphometry suggested that enhanced sensory processing was distinctively associated with PRMS.ConclusionsIn early‐stage PD, PRMS weighed different aspects of symptoms and more effectively predicted motor deterioration compared to CRMS, with distinctive brain structural characteristics. The superior sensitivity of PRMS to subtle declines in drug‐refractory symptoms like PIGD likely underlie our results, highlighting the importance of understanding the differential clinical implications of PRMS to prevent long‐term motor deterioration. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Title: Distinct Clinical Implications of Patient‐ Versus Clinician‐Rated Motor Symptoms in Parkinson's Disease
Description:
AbstractBackgroundPatient‐rated motor symptoms (PRMS) and clinician‐rated motor symptoms (CRMS) often differ in Parkinson's disease (PD).
ObjectiveOur goal was to investigate the determinants and clinical implications of PRMS compared with CRMS in PD.
MethodsThis retrospective, observational cohort study analyzed the cross‐sectional associations and longitudinal impacts of PRMS as assessed by the Movement Disorders Society‐sponsored Unified PD Rating Scale (MDS‐UPDRS) part 2, while controlling for CRMS measured by MDS‐UPDRS part 3.
Longitudinal analyses used Cox proportional hazards models and multiple linear mixed‐effects random intercepts/slope models, adjusting for many clinical predictors.
We conducted propensity score matching (PSM) to reinforce our analyses' robustness and surface‐based morphometry to investigate neural correlates.
ResultsWe enrolled 442 patients with early‐stage PD.
At baseline, regardless of CRMS, PRMS were associated with the severity of postural instability and gait disturbance (PIGD).
Notably, PRMS independently and more accurately predicted faster long‐term deterioration in motor function than CRMS (Hoehn and Yahr 4, adjusted hazard ratio per +1 point = 1.
19 [95% confidence intervals, 1.
08–1.
32]), particularly in PIGD (PIGD subscore, β‐interaction = 0.
052 [95% confidence intervals, 0.
018–0.
086]).
PSM confirmed these findings' robustness.
Surface‐based morphometry suggested that enhanced sensory processing was distinctively associated with PRMS.
ConclusionsIn early‐stage PD, PRMS weighed different aspects of symptoms and more effectively predicted motor deterioration compared to CRMS, with distinctive brain structural characteristics.
The superior sensitivity of PRMS to subtle declines in drug‐refractory symptoms like PIGD likely underlie our results, highlighting the importance of understanding the differential clinical implications of PRMS to prevent long‐term motor deterioration.
© 2024 The Author(s).
Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Social Listening – Revealing Parkinson’s Disease over Day and Night
Social Listening – Revealing Parkinson’s Disease over Day and Night
Abstract
Background: Nocturnal symptoms in Parkinson’s disease and their related burdens on patients are often treated after management of daytime manifestations. In order ...
Social Listening – Revealing Parkinson’s Disease over Day and Night
Social Listening – Revealing Parkinson’s Disease over Day and Night
Abstract
Background: Nocturnal symptoms in Parkinson’s disease are often treated after management of daytime manifestations. In order to better understand the unmet needs o...
Social Listening – Revealing Parkinson’s Disease over Day and Night
Social Listening – Revealing Parkinson’s Disease over Day and Night
Abstract
Background: Nocturnal symptoms in Parkinson’s disease are often treated after management of daytime manifestations. In order to better understand the unmet needs o...
Social Listening – Revealing Parkinson’s Disease over Day and Night
Social Listening – Revealing Parkinson’s Disease over Day and Night
Abstract
Background: Nocturnal symptoms in Parkinson’s disease are often treated after management of daytime manifestations. In order to better understand the unmet needs o...
Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer’s disease
Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer’s disease
Background: Affective symptoms in Alzheimer’s disease (AD) can be rated with both informant- and self-ratings. Information from these two modalities may not converge. We estimated ...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...

